Month: November 2016

ISPOR 19th ANNUAL EUROPEAN CONGRESS DREW KEY STAKEHOLDERS AND THOUGHT LEADERS TO DISCUSS ACCESS TO MEDICAL INNOVATIONS

Regulatory, Policy, and Financing Decisions in International Health Systems   Princeton, NJ—November 22, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) recently concluded its 19th Annual European Congress in Vienna, Austria. More than 4,700 delegates—stakeholders from all sectors of

Posted in Announcements, ISPOR News & Press Tagged with: , , , , , , , ,

BEST PODIUM AND POSTER PRESENTATIONS AWARDED AT ISPOR 19TH ANNUAL EUROPEAN CONGRESS

Princeton, NJ—November 22, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) recognized the Best Podium Presentation and Best Poster Presentation Awardees at its 19th Annual European Congress in Vienna, Austria.

Posted in Announcements, ISPOR News & Press Tagged with: ,

ISPOR CEO NANCY BERG WINS SILVER STEVIE® AWARD IN 2016 STEVIE AWARDS FOR WOMEN IN BUSINESS

Women Around the World Recognized at Event in New York City  Princeton, NJ—November 21,  2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) CEO and Executive Director Nancy Berg has been named the winner of a Silver Stevie® Award in

Posted in Announcements, ISPOR News & Press Tagged with: ,

ISPOR LAUNCHES “NEW PROFESSIONALS” NETWORK

Membership Category Designed to Serve Future HEOR Leaders Princeton, NJ—November 7, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today the launch of its New Professionals Network. The new membership category was designed to serve the unique needs

Posted in Announcements, ISPOR News & Press Tagged with:

ISPOR 19TH ANNUAL EUROPEAN CONGRESS FOCUSES ON THE USE OF REAL-WORLD DATA IN HEALTH TECHNOLOGY ASSESSMENT

Vienna, Austria—2 November 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held an issue panel this afternoon entitled, Using Observational (Real-World) Data in Health Technology Assessment: Route to Confusion or Better Decisions? The session took place at the Society’s

Posted in Announcements, ISPOR News & Press Tagged with: , , , ,

ISPOR RECOGNIZES FIVE DISTINGUISHED RECIPIENTS OF 2016 SERVICE AWARDS AT 19TH ANNUAL EUROPEAN CONGRESS

Awards Recognize Excellence in HEOR  Vienna, Austria—2 November 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) recognized recipients at its 19th Annual European Congress in Vienna, Austria. The ISPOR Awards Program is designed to foster and recognize excellence and

Posted in Announcements, ISPOR News & Press Tagged with: ,

PLENARY 3 OF ISPOR 19TH ANNUAL EUROPEAN CONGRESS EXPLORES KEY LESSONS FROM THE INTERQUALITY PROJECT

Focus on How to Control Costs and Improve Access Vienna, Austria—2 November 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) hosted its third plenary session, How to Control Costs and Improve Access to Medicines: Lessons from the InterQuality Project,

Posted in Announcements, ISPOR News & Press Tagged with: ,

ISPOR 19TH ANNUAL EUROPEAN CONGRESS EXAMINES INCLUSION OF FUTURE MEDICAL COSTS IN HEALTH TECHNOLOGY ASSESSMENT GUIDELINES

Vienna, Austria—2 November 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held an issue panel entitled, Should Health Technology Assessment Guidelines Recommend Inclusion of Future Medical Costs?, at the Society’s 19th Annual European Congress in Vienna, Austria. 

Posted in Announcements, ISPOR News & Press Tagged with: , ,

ISPOR 19TH ANNUAL EUROPEAN CONGRESS EXPLORES THE ASPIRATIONAL AND PRACTICAL ELEMENTS OF GENERATING REAL-WORLD EVIDENCE

Vienna, Austria—1 November 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) hosted an issue panel this afternoon entitled, Real World Evidence to Support Value Proposition and Reimbursement at Launch: The Aspirational Meets the Impractical?, at the Society’s 19th Annual

Posted in Announcements, ISPOR News & Press Tagged with: , ,

ISPOR 19TH ANNUAL EUROPEAN CONGRESS EXAMINES VALUE ASSESSMENT OF TRANSFORMATIVE MEDICINES IN RARE DISEASES

Vienna, Austria—1 November 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) offered a thought-provoking issue panel, Valuing Transformative Medicines in Rare Diseases: Methods and Madness, at the Society’s 19th Annual European Congress in Vienna, Austria. Paul Hodgkins, PhD, Vice

Posted in Announcements, ISPOR News & Press Tagged with: ,